| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/02/2007 | EP0869968B1 Growth-hormone secretagogues |
| 05/02/2007 | EP0733113B1 Influenza vaccine |
| 05/02/2007 | EP0725648B1 Hepatoselective pharmaceutical actives |
| 05/02/2007 | EP0689586B1 Vpr function and activity |
| 05/02/2007 | CN1957086A Adenovirus/alpha virus hybrid vector for the effective administration and expression of therapeutic genes in tumour cells |
| 05/02/2007 | CN1957085A Therapeutic peptides |
| 05/02/2007 | CN1957084A Bone marrow-relevant cell participating the maintenance and/or repair of tissue |
| 05/02/2007 | CN1957082A Novel galectin 9 modification protein and use thereof |
| 05/02/2007 | CN1956997A Mosaic soluble hyper IL-11 and use thereof |
| 05/02/2007 | CN1956994A Epithelial cell growth promoter |
| 05/02/2007 | CN1956735A Delivery agents for enhancing mucosal absorption of therapeutic agents |
| 05/02/2007 | CN1956728A Enzymes for pharmaceutical use |
| 05/02/2007 | CN1956727A Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 05/02/2007 | CN1956726A Composition and method for releasing mammal inflammation and oxidation stress |
| 05/02/2007 | CN1956718A Compositions comprising immunomodulatory compounds for the treatment and management of skin diseases and disorders, and method of using the same |
| 05/02/2007 | CN1956709A Dosage form containing the active ingredient cholylsarcosine |
| 05/02/2007 | CN1956705A Composition comprising colony stimulating factor for treatment of a localised bacterial infection and bacterial related disease |
| 05/02/2007 | CN1955192A Protein for promoting erythrocyte growth factor activity and its use |
| 05/02/2007 | CN1955191A New gene PPF1 of class I control infection nail forming efficiency and pathogenicity in flamentous etiological fungus and its use |
| 05/02/2007 | CN1955190A Polypeptide of controlling IIIv virus fusion and its use |
| 05/02/2007 | CN1954883A Method for stabilizing hemoglobin oxygen carrier sample |
| 05/02/2007 | CN1954882A Use of long active human recombination solubility tumor necrosin alpha receptor in preparation of medicine for treating hepatic failure |
| 05/02/2007 | CN1313611C Novel tumor wilting matter 2 ligand gene, its expressed tumor wilting matter and its preparation method |
| 05/02/2007 | CN1313606C Extraction method for SOD complex enzyme fine powder from corn |
| 05/02/2007 | CN1313494C Fusion protein possessing growth facilitation action and its coding gene and uses |
| 05/02/2007 | CN1313492C B-chain modified monomer quick-acting insulin and method for preparing same |
| 05/02/2007 | CN1313491C Cat omega interferon and its coding gene and uses |
| 05/02/2007 | CN1313490C Segregative technique for purifying stimulating factor of recombined human beta lymphocyte |
| 05/02/2007 | CN1313489C GP thymosin alpha 1 and preparation method |
| 05/02/2007 | CN1313487C Immunoreactive peptide Trpi possessing antibacterial action |
| 05/02/2007 | CN1313483C Inhibitory peptide of YMDD domain of duck hepatitis-B virus polymerase protein and application thereof |
| 05/02/2007 | CN1313482C Inhibition peptide of hepatatitis B virus polyzymoprotein YMDD functional region and its application |
| 05/02/2007 | CN1313481C Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof |
| 05/02/2007 | CN1313441C Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents |
| 05/02/2007 | CN1313439C Compounds and compositions for delivering active agents |
| 05/02/2007 | CN1313156C Sodium alginate microglobule blood vessel suppositery containing gynecoiatry medicine and its preparation method |
| 05/02/2007 | CN1313154C Medicine composition of adding active component which undissolved in water in carrier composition and its preparing method |
| 05/02/2007 | CN1313153C Use of immunoglobulin and cell growth factor in preparing medicine for asthma |
| 05/02/2007 | CN1313150C Therapeutic agent for treating autoimmune diseases |
| 05/02/2007 | CN1313149C Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis |
| 05/02/2007 | CN1313148C HSA-free formulations of interferon-Beta |
| 05/02/2007 | CN1313147C Treatment of inner ear hair cells |
| 05/02/2007 | CN1313146C Methods and compositions useful for inhibition of 'alpha'v'beta'5 mediated angiogenesis |
| 05/02/2007 | CN1313145C Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use |
| 05/02/2007 | CN1313082C Slow releasing composition and its preparing method |
| 05/01/2007 | USRE39606 Synthetic libraries of random oligomers, each member comprising an oligomer linked to a microchip encoded with information identifying structure of oligomer, for drug screening |
| 05/01/2007 | US7211659 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 05/01/2007 | US7211652 Protein from horn fly saliva that disrupts hemostasis |
| 05/01/2007 | US7211650 Separation of preferential protein from milk; obtain milk, transfer protease into whey layer, remove and recover protease from whey layer |
| 05/01/2007 | US7211649 Cartilage intermediate layer protein |
| 05/01/2007 | US7211648 Gag-peptide complex |
| 05/01/2007 | US7211646 Chondrosarcoma associated genes |
| 05/01/2007 | US7211570 Administering 5-substituted uracil-nucleosides or its pharmaceutically acceptable salt or prodrug for therapy of infected with Epstein-Barr virus or Kaposi's sarcoma-associated herpes ("KHSV") |
| 05/01/2007 | US7211566 a nonapeptide analog; antiinflammatory, antidiabetic agents, analgesics, antiastmatic agents |
| 05/01/2007 | US7211565 a 15 to 22-residue polypeptide analog that forms an amphipathic alpha helix in the presence of lipids; anticholesterol agents; hypercholesterolemia, cardiovascular disorders, atherosclerosis, restenosis, hypertriglyceridemia, high density lipoprotein deficiency, metabolic disorders |
| 05/01/2007 | US7211564 Methods and construction and screening of libraries of chemokine variants |
| 05/01/2007 | US7211563 For use in diagnosis, study, prophylaxis, and therapy of diseases and disorders related to body-weight regulation, metabolic diseases such as obesity, as well as related disorders such as adipositas, eating disorders, cachexia |
| 05/01/2007 | US7211562 cytotoxic agents followed by a heat shock protein 90 inhibitor, has a synergistic effect on the growth inhibition of cells; destroying cells having a cell proliferative disorder with wild-type retinoblastoma gene |
| 05/01/2007 | US7211561 Method for inducing selective cell death of malignant cells by activation of calcium-activated potassium channels (KCa) |
| 05/01/2007 | US7211560 Hemoglobulin for oxygen delivery; cardiovascular disorders; gastrointestinal disorders |
| 05/01/2007 | US7211559 Mutant factor VIII, substituting amino acidsin the A2 domain increases the circulating half-life and/or specific activity; procoagulant activity |
| 05/01/2007 | US7211558 Comprises nucleotide sequences coding recombinant antihemophilic factor for treatment of blood disorders |
| 05/01/2007 | US7211557 Use of GLP-1 analogs and derivatives administered peripherally in regulation of obesity |
| 05/01/2007 | US7211435 Telomerase expression repressor proteins and methods of using the same |
| 05/01/2007 | US7211424 Mammalian Subtilisin/kexin isozyme SKI-1: a proprotein convertase with a unique cleavage specificity |
| 05/01/2007 | US7211411 Human papilloma virus treatment |
| 05/01/2007 | US7211408 Comprising at least two regions, each region preferably having human T cell stimulating activity and each region comprising at least one T cell epitope derived from a protein antigen |
| 05/01/2007 | US7211405 Polypeptide for use in the detection of pregnancy complications |
| 05/01/2007 | US7211402 For selectively inhibiting signal transduction pathways using an active fragment of a p/CIP polypeptide or a nucleic acid molecule encoding such active fragment of a p/CIP polypeptide or a nucleic acid molecule encoding such an acive fragment |
| 05/01/2007 | US7211400 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens |
| 05/01/2007 | US7211399 Method for detecting leptin receptor ligands |
| 05/01/2007 | US7211398 Human genes and gene expression products: II |
| 05/01/2007 | US7211395 Serum albumin conjugate for use in the transfer and delivery of therapeutic agent to target |
| 05/01/2007 | US7211394 Providingformulation comprising a nascent protein comprising an affinity marker and a photocleavable detectable label, and ) a surface comprising an acceptor molecule; and interacting affinity marker with acceptor molecule so as to form a protein coated surface |
| 05/01/2007 | US7211379 Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2 |
| 05/01/2007 | US7211375 Methods for identifying compounds which modulate the activity of MSH5 |
| 05/01/2007 | US7211278 Treating method for suppressing hair growth |
| 05/01/2007 | US7211271 Method to improve hydroxyapatite implantation and stimulate bone regeneration |
| 05/01/2007 | US7211269 peptide of sequence (Gly-Pro-Gln)n-NH2, wherein n ranges between 1 and 3; to enhance skin appearance |
| 05/01/2007 | US7211263 Use of adenylate cyclase or bacteria producing it as vaccines against Bordetella |
| 05/01/2007 | US7211262 Burn pain treatment by peripheral administration of a neurotoxin |
| 05/01/2007 | US7211261 Stable liquid formulations of botulinum toxin |
| 05/01/2007 | US7211259 4-1BB polypeptides and DNA encoding 4-1BB polypeptides |
| 05/01/2007 | US7211258 Protein A compositions and methods of use |
| 05/01/2007 | US7211257 Methods for inducing apoptosis in ovarian carcinoma cells using an anti-regeneration and tolerance factor antibody |
| 05/01/2007 | US7211256 Administering to mammal polyclonal or monoclonal antibody, wherein polyclonal or monoclonal antibody recognizes an epitope of a protein of 48,000 daltons determined by immunoblot, wherein protein is a surface protein of a merozoite of Plasmodium falciparum |
| 05/01/2007 | US7211255 Contacting male ejaculate, prior to contact with a female egg, with an effective anti-fertility amount of a pharmaceutical composition, which comprises an antibody that binds a surface exposed epitope of SP22, and a pharmaceutically acceptable carrier |
| 05/01/2007 | US7211254 Nucleotide sequences coding interleukin-9 induced calcium activated chloride channel for use in identifying modulators for treatment and prevention of asthma, allergies and respiratory system disorders |
| 05/01/2007 | US7211253 Erythropoietin forms with improved properties |
| 05/01/2007 | US7211252 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
| 05/01/2007 | US7211251 Antibodies to transferrin receptor-like proteins |
| 05/01/2007 | US7211250 Method and composition for inhibiting cancer cell growth |
| 05/01/2007 | US7211249 Heat-generating composition for topical application to skin |
| 05/01/2007 | US7211246 Compositions comprising oestrone-3-0-sulphamate and trail (TNF-related apoptosis inducing ligand) |
| 05/01/2007 | CA2452032C Synergistic antimicrobial compositions and methods of inhibiting biofilm formation |
| 05/01/2007 | CA2296036C Dolastatin 15 derivatives |
| 05/01/2007 | CA2284133C Novel cell line and screening method with the use of the same |
| 05/01/2007 | CA2269594C Use of complexes for the preparation of compositions for the treatment of sensitive skin, preparation process and hypoallergenic compositions |
| 05/01/2007 | CA2234585C Prolonged release of gm-csf |
| 05/01/2007 | CA2227205C Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles |